Cyclin-dependent kinase inhibitory protein expression in human choroidal melanoma tumors

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 10, 2000, Pages 2837-2843

  Mouriaux, F ^a   Maurage, C A ^a   Labalette, P ^a   Sablonniere, B ^a   Malecaze, F ^a   Darbon, J M ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; KI 67 ANTIGEN; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P53;

ARTICLE; CANCER INVASION; CARCINOGENESIS; CELL CYCLE; CHOROID MELANOMA; HUMAN; HUMAN TISSUE; MITOSIS INDEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; UVEA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NUCLEAR; BLOTTING, WESTERN; CHOROID NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MELANOMA; MICROFILAMENT PROTEINS; MIDDLE AGED; MUSCLE PROTEINS; NUCLEAR PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033823787     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Cyclins and cancer: Cyclin D and CDK inhibitors come of age
2. A cell cycle regulator potentially involved in genesis of many tumor types
3. P53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage
4. Induction of WAF1/CIP1 by a p53-independent pathway
5. P53-independent expression of p21 in muscle and other terminally differentiated cells
6. P53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma
7. The p21 inhibitor of the cyclin-dependent kinases controls DNA replication by interacting with PCNA
8. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair
9. Mice lacking p27 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors
10. Enhanced growth of mice lacking the cyclin-dependent kinases inhibitor function of p27
11. Decreased levels of the cell cycle inhibitor p27 protein: Prognostic implications in primary breast cancer
12. Increased proteasome-dependent degradation of the cyclin dependent kinase inhibitor p27 in aggressive colorectal carcinomas
13. Expression of cell-cycle regulators p27 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
14. Prognosis role of cyclin dependent kinase inhibitor p27 in non-small cell lung cancer
15. Overexpression of the cyclin-dependent kinase inhibitor p21 in human cutaneous malignant melanoma
16. Differential-associated overexpression of the cyclin-dependent kinase inhibitor p21 in human cutaneous squamous cell carcinoma
17. Increased levels of p21 in human brain tumors
18. Absence of WAF1 mutations in a variety of human malignancies
19. Somatic mutations of the WAF1/ CIP1 gene in primary prostate cancer
20. P27 chromosomal mapping to 12p 12-12p13 and absence of mutations in human tumors
21. Molecular analysis of the cyclin-dependent kinase inhibitor p27 in human malignancies
22. P27/Kip1 mutation found in breast cancer
23. Rates of p16(MTS1) mutations in primary tumors with 9p loss
24. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancer
25. Germline p16 mutations in familial melanoma
26. Melanoma of the eye and other non cutaneous sites: Epidemiologic aspects
27. Melanotic tumors of the uvea
28. Reappraisal of Callender's spindle A type of malignant melanoma of choroid and ciliary body
29. Prognostic factors in small malignant melanomas of choroid and ciliary body
30. Mean of the ten largest nucleoli, microcirculation architecture, and prognosis of ciliochoroidal melanomas
31. COMS Report no. 6. Histopathologic characteristics of uveal melanomas in eyes enucleated
32. Differential expression of G1 cyclins and CDK-inhibitory proteins in normal and transformed human choroidal melanocytes
33. Dystrophin-glycoprotein complex in highly enriched in isolated skeletal muscle sarcolemma
34. Topological control of p21 expression in normal and neoplasic tissues
35. Expression of cyclin-dependent kinase inhibitor p21 in non-neoplasic mucosa and neoplasia of the stomach: Relationship with p53 status and proliferative activity
36. Expression of p21 is heterogeneous and unrelated to proliferation index in human ovarian carcinoma
37. Cyclin kinase inhibitor p21 in malignant melanoma
38. Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma
39. Clinical implications of the p53 tumor suppressor gene
40. P21 and p53 protein expression in breast cancer
41. Nuclear accumulation of p53 correlates significantly with clinical feature and inversely with the expression of the cyclin-dependent kinase inhibitor p21 in pancreatic cancer
42. Increased expression and mutation of p53 in choroidal melanoma
43. p53 Gene and cell cycling in uveal melanoma
44. p53 Expression in uveal malignant melanomas
45. p53 Oncoprotein overexpression in choroidal melanoma
46. Loss of expression of the p16/cyclin-dependent kinase 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression
47. Loss of expression of the p16 gene in cutaneous malignant melanoma correlates with tumor cell proliferation
48. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma
49. Analysis of p16 alterations in primary sporadic uveal melanoma
50. Choroidal nevi in a white population
51. Differential expression and cell cycle regulation of the cyclin-dependent-kinase4 inhibitor p16
52. P27: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers
53. 1 in malignant melanoma: Inverse correlation with disease free-survival
54. Positive correlation between p27 expression and progression of human esophageal squamous cell carcinoma
55. Expression of cylin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas-prognostic implications
56. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67
57. Monoclonal antibody Ki-67: Its use in histopathology
58. Aberrant p27 expression in endocrine and other tumors
59. Role of p27 and cyclin dependent kianse 2 in the proliferation of non-small cell lung cancer
60. Expression of the cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms
61. Cytoplasmic displacement of cyclin E-CDK2 inhibitors p21 and p27 in anchorage-independent cells
62. Cleavage of p21 and p27 mediated apoptosis in endothelial cells through activation of CDK2: Role of caspase cascade
63. p21 Expression is increased by irradiation in esophageal squamous cell carcinoma
64. p53 Gene mutations and p21 protein expression induced independently of p53, by TGF-beta and gamma-rays in squamous cell carcinoma cells
65. Induction of cellular p53 activity by DNA-damaging agents and growth arrest
66. Regulatory role of p27kip1 in the mouse and human testis
67. Ki-67 immuno-staining in uveal melanoma
68. A histologic study in uveal melanomas after brachytherapy with ruthenium plaques